CALGB 90601: Comparing gemcitabine and cisplatin with bevacizumab to placebo for metastatic urothelial carcinoma
CALGB 90601: Comparing gemcitabine and cisplatin with bevacizumab to placebo for metastatic urothelial carcinoma
NILE: Should we give everything to patients with unresectable locally advanced or metastatic urothelial cancer?
Maintenance pembrolizumab vs placebo for metastatic urothelial cancer
CheckMate-142: Updated data from MSI high metastatic colon cancer patients
ASCO 2019 and vision for cancer control
SWOG 1314: A study of co-expression extrapolation (COXEN) with neoadjuvant chemotherapy for muscle-invasive bladder cancer
Better education about breast cancer treatment in Africa
A severe lack of cancer care in Burundi
Predictive models for treatment risk in cancer
Improving radiotherapy access in Africa
Cervical cancer screening in North Macedonia
The Global Health Catalyst initiative